Amedisys (NASDAQ:AMED) Earns Equal Weight Rating from Stephens
Amedisys (NASDAQ:AMED – Get Free Report)‘s stock had its “equal weight” rating reaffirmed by stock analysts at Stephens in a research note issued on Tuesday,Benzinga reports. They currently have a $101.00 price objective on the health services provider’s stock. Stephens’ price objective points to a potential upside of 9.75% from the stock’s previous close. Amedisys […]
Amedisys (NASDAQ:AMED – Get Free Report)‘s stock had its “equal weight” rating reaffirmed by stock analysts at Stephens in a research note issued on Tuesday,Benzinga reports. They currently have a $101.00 price objective on the health services provider’s stock. Stephens’ price objective points to a potential upside of 9.75% from the stock’s previous close. Amedisys […]
